• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

G蛋白偶联受体激酶6在胶质瘤中过表达并促进胶质瘤细胞增殖。

G protein-coupled receptor kinase 6 is overexpressed in glioma and promotes glioma cell proliferation.

作者信息

Xu Li-Quan, Tan Shu-Bin, Huang Shan, Ding He-Yuan, Li Wen-Gang, Zhang Yi, Li Shi-Qi, Wang Tao

机构信息

Department of Neurosurgery, Shanghai 5th People's Hospital, Shanghai Medical College, Fudan University, Shanghai, 200240, China.

Department of Endocrinology, Shanghai 5th People's Hospital, Shanghai Medical College, Fudan University, Shanghai, 200240, China.

出版信息

Oncotarget. 2017 Apr 18;8(33):54227-54235. doi: 10.18632/oncotarget.17203. eCollection 2017 Aug 15.

DOI:10.18632/oncotarget.17203
PMID:28903336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5589575/
Abstract

The expression and potential biological functions of G protein-coupled receptor kinase 6 (GRK6) in human glioma are tested in this study. We show that protein and mRNA expression of GRK6 in human glioma tissues was significantly higher than that in the normal brain tissues. Further immunohistochemistry assay analyzing total 118 human glioma tissues showed that GRK6 over-expression was correlated with glioma pathologic grade and patients' Karnofsky performance status (KPS) score. At the molecular level, in the GRK6-low H4 glioma cells, forced over-expression of GRK6 promoted cell proliferation. Reversely, siRNA-mediated knockdown of GRK6 in the U251MG (GRK6-high) cells led to proliferation inhibition and cell cycle arrest. Intriguingly, GRK6 could also be an important temozolomide resistance factor. Temozolomide-induced cytotoxicity was prominent only in GRK6-low H4 glioma cells. On the other hand, knockdown of GRK6 by targeted siRNA sensitized U251MG cells (GRK6-high) to temozolomide. Thus, GRK6 over-expression in glioma is important for cell proliferation and temozolomide resistance.

摘要

本研究检测了G蛋白偶联受体激酶6(GRK6)在人类胶质瘤中的表达及潜在生物学功能。我们发现,GRK6在人类胶质瘤组织中的蛋白质和mRNA表达显著高于正常脑组织。进一步对总共118例人类胶质瘤组织进行免疫组织化学分析表明,GRK6的过表达与胶质瘤病理分级及患者的卡氏功能状态(KPS)评分相关。在分子水平上,在GRK6低表达的H4胶质瘤细胞中,GRK6的强制过表达促进细胞增殖。相反,在U251MG(GRK6高表达)细胞中,siRNA介导的GRK6敲低导致增殖抑制和细胞周期停滞。有趣的是,GRK6也可能是一个重要的替莫唑胺耐药因子。替莫唑胺诱导的细胞毒性仅在GRK6低表达的H4胶质瘤细胞中显著。另一方面,靶向siRNA敲低GRK6使U251MG细胞(GRK6高表达)对替莫唑胺敏感。因此,胶质瘤中GRK6的过表达对细胞增殖和替莫唑胺耐药性很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ece/5589575/02941dc2a9b2/oncotarget-08-54227-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ece/5589575/5db376c19d11/oncotarget-08-54227-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ece/5589575/75a7fec05cbf/oncotarget-08-54227-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ece/5589575/f57233481214/oncotarget-08-54227-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ece/5589575/2305ed7c68f6/oncotarget-08-54227-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ece/5589575/02941dc2a9b2/oncotarget-08-54227-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ece/5589575/5db376c19d11/oncotarget-08-54227-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ece/5589575/75a7fec05cbf/oncotarget-08-54227-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ece/5589575/f57233481214/oncotarget-08-54227-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ece/5589575/2305ed7c68f6/oncotarget-08-54227-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ece/5589575/02941dc2a9b2/oncotarget-08-54227-g005.jpg

相似文献

1
G protein-coupled receptor kinase 6 is overexpressed in glioma and promotes glioma cell proliferation.G蛋白偶联受体激酶6在胶质瘤中过表达并促进胶质瘤细胞增殖。
Oncotarget. 2017 Apr 18;8(33):54227-54235. doi: 10.18632/oncotarget.17203. eCollection 2017 Aug 15.
2
[Effect of G Protein-coupled Receptor Kinase 6 on Proliferation and Apoptosis of Multiple Myeloma Cells and Its Mechanisms].G蛋白偶联受体激酶6对多发性骨髓瘤细胞增殖和凋亡的影响及其机制
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Dec;24(6):1801-1806. doi: 10.7534/j.issn.1009-2137.2016.06.033.
3
MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells.微小RNA-16通过调控人胶质瘤细胞中的BCL-2来调节替莫唑胺耐药性。
Int J Clin Exp Pathol. 2015 Oct 1;8(10):12698-707. eCollection 2015.
4
G protein-coupled receptor kinase 6 (GRK6) selectively regulates endogenous secretin receptor responsiveness in NG108-15 cells.G蛋白偶联受体激酶6(GRK6)选择性调节NG108-15细胞中内源性促胰液素受体的反应性。
Br J Pharmacol. 2003 Feb;138(4):660-70. doi: 10.1038/sj.bjp.0705101.
5
STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.信号转导和转录激活因子1(STAT-1)的表达在恶性胶质瘤细胞中受胰岛素样生长因子结合蛋白3(IGFBP-3)调控,并且是胶质母细胞瘤患者生存预后不良的有力预测指标。
J Neurosurg. 2014 Aug;121(2):374-83. doi: 10.3171/2014.4.JNS131198. Epub 2014 May 30.
6
B-cell CLL/lymphoma 3 promotes glioma cell proliferation and inhibits apoptosis through the oncogenic STAT3 pathway.B细胞慢性淋巴细胞白血病/淋巴瘤3通过致癌性信号转导子和转录激活子3(STAT3)途径促进胶质瘤细胞增殖并抑制其凋亡。
Int J Oncol. 2016 Dec;49(6):2471-2479. doi: 10.3892/ijo.2016.3729. Epub 2016 Oct 12.
7
G protein-coupled receptor kinase 6 controls post-inflammatory visceral hyperalgesia.G蛋白偶联受体激酶6控制炎症后内脏痛觉过敏。
Brain Behav Immun. 2009 Jan;23(1):18-26. doi: 10.1016/j.bbi.2008.07.006. Epub 2008 Jul 22.
8
Aberrant GRK6 promoter methylation is associated with poor prognosis in hypopharyngeal squamous cell carcinoma.异常的GRK6启动子甲基化与下咽鳞状细胞癌的不良预后相关。
Oncol Rep. 2016 Feb;35(2):1027-33. doi: 10.3892/or.2015.4469. Epub 2015 Dec 1.
9
MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide.微小RNA-93促进人胶质瘤细胞的恶性表型并诱导其对替莫唑胺的化学抗性。
Biol Open. 2016 Jun 15;5(6):669-77. doi: 10.1242/bio.015552.
10
Alternative splicing produces transcripts encoding four variants of mouse G-protein-coupled receptor kinase 6.可变剪接产生编码小鼠G蛋白偶联受体激酶6四种变体的转录本。
Genomics. 1999 Sep 1;60(2):199-209. doi: 10.1006/geno.1999.5901.

本文引用的文献

1
Preclinical study of cinobufagin as a promising anti-colorectal cancer agent.华蟾毒精作为一种有前景的抗结直肠癌药物的临床前研究。
Oncotarget. 2017 Jan 3;8(1):988-998. doi: 10.18632/oncotarget.13519.
2
The anti-cancer activity of the mTORC1/2 dual inhibitor XL388 in preclinical osteosarcoma models.mTORC1/2双重抑制剂XL388在临床前骨肉瘤模型中的抗癌活性。
Oncotarget. 2016 Aug 2;7(31):49527-49538. doi: 10.18632/oncotarget.10389.
3
Aqueous Oldenlandia diffusa extracts inhibits colorectal cancer cells via activating AMP-activated protein kinase signalings.
白花蛇舌草水提取物通过激活AMP活化蛋白激酶信号通路抑制结肠癌细胞。
Oncotarget. 2016 Jul 19;7(29):45889-45900. doi: 10.18632/oncotarget.9969.
4
Aberrant GRK6 promoter methylation is associated with poor prognosis in hypopharyngeal squamous cell carcinoma.异常的GRK6启动子甲基化与下咽鳞状细胞癌的不良预后相关。
Oncol Rep. 2016 Feb;35(2):1027-33. doi: 10.3892/or.2015.4469. Epub 2015 Dec 1.
5
Icaritin activates JNK-dependent mPTP necrosis pathway in colorectal cancer cells.淫羊藿素激活结肠癌细胞中JNK依赖的线粒体通透性转换孔坏死途径。
Tumour Biol. 2016 Mar;37(3):3135-44. doi: 10.1007/s13277-015-4134-3. Epub 2015 Oct 1.
6
G-protein-coupled receptor kinases in inflammation and disease.炎症与疾病中的G蛋白偶联受体激酶
Genes Immun. 2015 Sep;16(6):367-77. doi: 10.1038/gene.2015.26. Epub 2015 Jul 30.
7
Neuro-oncology: The many challenges of treating elderly glioblastoma patients.神经肿瘤学:治疗老年胶质母细胞瘤患者面临的诸多挑战。
Nat Rev Neurol. 2015 Jul;11(7):374-5. doi: 10.1038/nrneurol.2015.82. Epub 2015 May 19.
8
Cancer statistics, 2015.癌症统计数据,2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
9
Pre-clinical evaluation of AZD-2014, a novel mTORC1/2 dual inhibitor, against renal cell carcinoma.新型mTORC1/2双重抑制剂AZD-2014抗肾细胞癌的临床前评估
Cancer Lett. 2015 Feb 28;357(2):468-75. doi: 10.1016/j.canlet.2014.11.012. Epub 2014 Nov 12.
10
Molecular basis for small molecule inhibition of G protein-coupled receptor kinases.小分子抑制G蛋白偶联受体激酶的分子基础。
ACS Chem Biol. 2015 Jan 16;10(1):246-56. doi: 10.1021/cb5003976. Epub 2014 Jul 14.